Skip to main content

2 Result(s)

within Preecha Tantanathip Remove this filter

and

  1. Article

    Open Access

    Renal impairment after switching from stavudine/lamivudine to tenofovir/lamivudine in NNRTI-based antiretroviral regimens

    During stavudine phase-out plan in develo** countries, tenofovir is used to substitute stavudine. However, knowledge regarding whether there is any difference of the frequency of renal injury between tenofov...

    Weerawat Manosuthi, Wiroj Mankatitham, Aroon Lueangniyomkul… in AIDS Research and Therapy (2010)

    Download PDF (974 KB) View Article

  2. Article

    Open Access

    Durability of Stavudine, Lamivudine and Nevirapine among Advanced HIV-1 Infected Patients with/without Prior Co-administration of Rifampicin: A 144-week Prospective Study

    To date, data on the durability of a regimen of stavudine, lamivudine and nevirapine are very limited, particularly from the resource-limited settings.

    Weerawat Manosuthi, Preecha Tantanathip, Wisit Prasithisirikul… in BMC Infectious Diseases (2008)

    Download PDF (307 KB) View Article